Furthermore, STAT5 activation is targetable in cutaneous T cell lymphomas, bearing STAT5A and STAT5B copy number gains, and PDGFRβ-driven anaplastic large cell lymphoma (55, 60). This evidence concerns the gene PDGFRB and primary cutaneous T-cell non-Hodgkin lymphoma.